145 related articles for article (PubMed ID: 36844735)
1. Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J'xactly study.
Migita S; Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A
Front Cardiovasc Med; 2023; 10():1074661. PubMed ID: 36844735
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Kobayashi T; Niwa A; Matsuo H; Yokoi H; Koga M; Yamazaki T; Hirayama A;
Circ J; 2020 Oct; 84(11):1912-1921. PubMed ID: 32981924
[TBL] [Abstract][Full Text] [Related]
3. Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism - Subanalysis of the J'xactly Study.
Nakamura M; Fukuda I; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Okumura Y; Hirayama A;
Circ Rep; 2023 Apr; 5(4):144-151. PubMed ID: 37025939
[No Abstract] [Full Text] [Related]
4. Effectiveness and safety of rivaroxaban in patients with venous thromboembolism and active cancer: A subanalysis of the J'xactly study.
Hisatake S; Ikeda T; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Mo M; Yamazaki T; Okumura Y; Hirayama A;
J Cardiol; 2023 Mar; 81(3):268-275. PubMed ID: 36400414
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and clinical outcomes of Japanese patients with venous thromboembolism receiving under-dose rivaroxaban: subanalysis of J'xactly.
Fukamachi D; Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
Curr Med Res Opin; 2022 Jul; 38(7):1059-1068. PubMed ID: 35502571
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J'xactly study.
Migita S; Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
Thromb J; 2023 Aug; 21(1):88. PubMed ID: 37599351
[TBL] [Abstract][Full Text] [Related]
7. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
BMJ Open; 2018 Jun; 8(6):e020286. PubMed ID: 29934383
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism - Insights From the J'xactly Study.
Yamashita T; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Ikeda T; Mo M; Yamazaki T; Okumura Y; Hirayama A;
Circ Rep; 2022 Aug; 4(8):371-377. PubMed ID: 36032386
[No Abstract] [Full Text] [Related]
9. Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism - Subanalysis of the J'xactly Study.
Hisatake S; Ikeda T; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Mo M; Yamazaki T; Okumura Y; Hirayama A;
Circ Rep; 2022 Oct; 4(10):490-498. PubMed ID: 36304427
[No Abstract] [Full Text] [Related]
10. Effectiveness and safety of the direct oral anticoagulant in acute distal deep vein thrombosis: From the prospective multicenter observational study, J'xactly, in Japan.
Mo M; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Yamazaki T; Okumura Y; Hirayama A;
Phlebology; 2023 Feb; 38(1):4-15. PubMed ID: 36433754
[TBL] [Abstract][Full Text] [Related]
11. Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J'xactly Study.
Yamada N; Fukuda I; Nakamura M; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Okumura Y; Hirayama A
Ann Vasc Dis; 2023 Sep; 16(3):181-188. PubMed ID: 37779650
[No Abstract] [Full Text] [Related]
12. The prediction role of D-dimer in recurrence of venous thromboembolism 1-year after anticoagulation discontinuing following idiopathic deep vein thrombosis.
Tamizifar B; Oghab P; Esfahani MA
J Res Med Sci; 2014 Jul; 19(7):586-91. PubMed ID: 25364355
[TBL] [Abstract][Full Text] [Related]
13. Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.
Nakamura M; Sakon M; Sasako M; Okusaka T; Mukai H; Fujiwara K; Kunitoh H; Oba MS; Wada H; Hosokawa J; Takita A; Ikeda M
Int J Clin Oncol; 2024 Apr; 29(4):407-416. PubMed ID: 38430303
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry.
Ohsumi S; Watanabe K; Kondo N; Kosaka Y; Ishikawa T; Kitahara M; Kubo S; Oba MS; Kimura T; Takita A; Mukai H
Breast Cancer; 2023 Jul; 30(4):607-616. PubMed ID: 37069366
[TBL] [Abstract][Full Text] [Related]
15. Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: A systematic review and meta-analysis.
Chi G; Lee JJ; Memar Montazerin S; Marszalek J
Vasc Med; 2022 Oct; 27(5):478-486. PubMed ID: 35913041
[TBL] [Abstract][Full Text] [Related]
16. Elevated Plasma D-Dimer Level Is Associated With Short-Term Risk of Ischemic Stroke in Patients With Acute Heart Failure.
Hamatani Y; Nagai T; Nakai M; Nishimura K; Honda Y; Nakano H; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Toyoda K; Yasuda S; Yokoyama H; Ogawa H; Anzai T;
Stroke; 2018 Jul; 49(7):1737-1740. PubMed ID: 29880555
[TBL] [Abstract][Full Text] [Related]
17. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
Prins MH; Lensing AW; Brighton TA; Lyons RM; Rehm J; Trajanovic M; Davidson BL; Beyer-Westendorf J; Pap ÁF; Berkowitz SD; Cohen AT; Kovacs MJ; Wells PS; Prandoni P
Lancet Haematol; 2014 Oct; 1(1):e37-46. PubMed ID: 27030066
[TBL] [Abstract][Full Text] [Related]
18. D-dimer monitoring combined with ultrasonography improves screening for asymptomatic venous thromboembolism in acute spinal cord injury.
Kumagai G; Wada K; Kudo H; Asari T; Ichikawa N; Ishibashi Y
J Spinal Cord Med; 2020 May; 43(3):353-357. PubMed ID: 30199352
[No Abstract] [Full Text] [Related]
19. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
[TBL] [Abstract][Full Text] [Related]
20. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
